Physician profile
Brian Walter Bernstein
NPI 1447712443
$2,826.44
in general payments reported to CMS, 2019-2025
18 companies · $719 in 2025
The $719 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $615 · 2023: $693 · 2024: $636 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $690.30 | 2021-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $464.43 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Axsome Therapeutics, INC. | $273.40 | 2023-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $231.90 | 2021-2025 | Ingrezza |
| Abbvie INC. | $222.42 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $206.34 | 2021-2023 | Invega Trinza, Invega Sustenna, Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $177.96 | 2022-2025 | Caplyta |
| Corium, LLC | $162.48 | 2023-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $111.83 | 2021-2024 | Trintellix |
| Lundbeck LLC | $53.77 | 2023-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $48.12 | 2022-2024 | |
| Vanda Pharmaceuticals INC. | $46.11 | 2025 | Fanapt |
| Tris Pharma INC | $45.65 | 2023 | Dyanavel Xr |
| Noven Therapeutics, LLC | $23.27 | 2024 | Xelstrym, Secuado |
| Idorsia Pharmaceuticals US INC | $21.59 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $17.78 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 2025 | Cobenfy |
| Ironshore Pharmaceuticals INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.